CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Lifecore Biomedical Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Lifecore Biomedical Inc
3515 Lyman Boulevard
Phone: (952) 368-4300p:952 368-4300 CHASKA, MN  55318  United States Ticker: LFCRLFCR

On October 30, 2023, the Audit Committee of the Board of Directors of Lifecore Biomedical, Inc., after discussion with management, concluded that the company’s previously issued consolidated financial statements as of and for the fiscal years ended May 29, 2022 and May 30, 2021, the company’s unaudited consolidated financial statements as of and for the periods ending August 30, 2020, November 29, 2020, February 28, 2020, August 29, 2021, November 28, 2021, February 27, 2022, August 28, 2022, November 27, 2022 and February 26, 2023, should no longer be relied upon. This determination resulted from the company’s identification of errors in the Non-Reliance Periods related to the calculation of capitalized interest, valuation of inventories, and certain adjustments related to previously divested businesses.

Business Summary
Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO). The Company designs, develops, manufactures and sells differentiated products for biomaterials markets and license technology applications to partners. The Company offers highly differentiated capabilities in the development, fill and finish of sterile, injectable-grade pharmaceutical products in syringes and vials. It is involved in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a spectrum of medical conditions and procedures. The Company uses its fermentation process and aseptic formulation and filling expertise to develop HA-based products for multiple applications and to take advantage of non-HA devices and drug opportunities.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
5/28/20235/28/2023YesYes---

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Non-Executive Independent Chairman of the Board Craig A.Barbarosh 55 10/14/2020 1/1/2019
Director James G.Hall 60 5/20/2024 6/1/2017
Chief Financial Officer, Company Secretary John D.Morberg 58 1/18/2021 1/18/2021
4 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Apio, Inc. 4575 West Main St. Guadalupe CA United States
Curation Foods, Inc. 2811 Airpark Dr Santa Maria CA United States
LANDEC AG, INC. 201 N MICHIGAN ST OXFORD IN
GreenLine Foods, Inc. 8600 S Wilkinson Way Perrysburg OH United States

Business Names
Business Name
Apio, Inc.
GreenLine Foods, Inc.
Landec Ag, LLC
4 additional Business Names available in full report.

General Information
Number of Employees: 459 (As of 5/28/2023)
Outstanding Shares: 30,546,936 (As of 3/14/2024)
Shareholders: 47
Stock Exchange: NASD
Federal Tax Id: 943025618
Fax Number: (302) 636-5454
Email Address: spowell@landec.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, March 28, 2024